• Science & Technology

Genetic discovery could guide treatment for aggressive childhood cancer

A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment. A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment.

28 June 2021

• Health & Medicine

Men’s skin cancer rates increase by 50% over decade

Over the last 10 years, melanoma skin cancer among men in the UK has increased by almost 50%. Over the last 10 years, melanoma skin cancer among men in the UK has increased by almost 50%.

24 June 2021

• Science & Technology
• Health & Medicine

Scientists trial new way to boost CAR T-cell therapy

Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that ‘reboots’ a treatment for some people with blood cancer whose cancer starts to come back. Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that ‘reboots’ a treatment for some people with blood cancer whose cancer starts to come back.

23 June 2021

• Health & Medicine

Cancer Research UK spin-out gets US approval to trial unique T-cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.   Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.  

18 June 2021

• Health & Medicine

Ground-breaking trial pilots new tests to detect lung cancer earlier

The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable. The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable.

16 June 2021

• Health & Medicine

Combination immunotherapy for advanced bowel cancer approved for NHS in England

People who have previously been treated for a type of bowel cancer that has spread to other parts of their body will now have another treatment option in England. People who have previously been treated for a type of bowel cancer that has spread to other parts of their body will now have another treatment option in England.

16 June 2021

• Health & Medicine

Fears breast cancer progress could stall due to COVID-19 backlog

Around 10,600 fewer breast cancer patients have started treatment in the last year in England, as experts fear hard-won progress could slow. Around 10,600 fewer breast cancer patients have started treatment in the last year in England, as experts fear hard-won progress could slow.

15 June 2021

• Science & Technology
• Health & Medicine

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented. One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented.

9 June 2021

• Health & Medicine

New hormone treatment for advanced prostate cancer made available in England

Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England. Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.

8 June 2021

• Science & Technology

Scientists find cells in centre of tumours are most likely to spread

The new findings shed light on how cancer cells found in different parts of a tumour behave differently. The new findings shed light on how cancer cells found in different parts of a tumour behave differently.

19 May 2021

• Health & Medicine

Research shows one size doesn’t fit all for cervical screening in the trans and non-binary community

Dr Alison Berner and team asked 140 trans men and non-binary people to share their past experiences and attitudes towards cervical screening. Dr Alison Berner and team asked 140 trans men and non-binary people to share their past experiences and attitudes towards cervical screening.

18 May 2021

• Health & Medicine

Cancer Research UK spin-out goes public, ready to invest more in precision T cell therapies

Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO). Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).

18 May 2021